Related Experiment Video
Updated: May 7, 2026
Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury
Published on: December 17, 2014
A Review of the Potential Use of Antioxidants in Spinal Cord Injuries
Agnieszka Nowacka1, Maciej Śniegocki1, Ewa Ziółkowska2
1Department of Neurosurgery, Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, ul. Curie Skłodowskiej 9, 85-094 Bydgoszcz, Poland.
Abstract:
Spinal cord injury (SCI) is a debilitating neurological condition marked by primary mechanical damage followed by a complex secondary injury cascade, in which oxidative stress plays a central role. Mitochondrial dysfunction, ionic imbalance, and inflammatory responses drive excessive generation of reactive oxygen and nitrogen species, leading to lipid peroxidation, protein and DNA damage, apoptosis, and progressive neurological impairment. Antioxidant-based therapies have emerged as promising neuroprotective strategies, with compounds such as A91 peptide, curcumin, edaravone, ginsenosides, and glutathione demonstrating preclinical efficacy in reducing oxidative damage, restoring redox balance, modulating signaling pathways (e.g., Nrf2, NF-κB, MAPK, PI3K/Akt), and enhancing neuronal survival. While therapeutic outcomes depend on injury severity, timing, and combinatorial approaches, translating these findings into clinical practice and integrating antioxidants with cell-based therapies, biomaterials, and rehabilitation offers a critical avenue for improving functional recovery in SCI.
Insights
Spinal cord injury (SCI) involves oxidative stress damaging the nervous system. Antioxidant therapies show promise in preclinical studies for neuroprotection and improving functional recovery in SCI.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Spinal cord injury (SCI) causes significant neurological impairment.
- Oxidative stress is a key factor in the secondary injury cascade following SCI.
- Mitochondrial dysfunction and inflammation exacerbate oxidative damage.
Purpose of the Study:
- To review the role of oxidative stress in SCI.
- To evaluate the neuroprotective potential of antioxidant-based therapies for SCI.
- To explore strategies for translating antioxidant therapies into clinical practice for SCI.
Main Methods:
- Review of preclinical studies on antioxidant compounds (A91 peptide, curcumin, edaravone, ginsenosides, glutathione).
- Analysis of mechanisms including reduction of oxidative damage, redox balance restoration, and modulation of signaling pathways (Nrf2, NF-κB, MAPK, PI3K/Akt).
- Assessment of factors influencing therapeutic outcomes.
Main Results:
- Antioxidants demonstrate preclinical efficacy in reducing oxidative damage and neuronal death.
- These compounds modulate key signaling pathways involved in neuroprotection.
- Restoration of redox balance and enhancement of neuronal survival are observed.
Conclusions:
- Antioxidant therapies are promising for neuroprotection in SCI.
- Therapeutic success is influenced by injury severity, treatment timing, and combination strategies.
- Integrating antioxidants with cell-based therapies, biomaterials, and rehabilitation is crucial for functional recovery in SCI.
Related Concept Videos
01:14Spinal Cord Injury ll: Pathophysiology
01:25Secondary Spinal Cord Injury llI: Pathophysiology